IDEXX Laboratories (IDXX) Revenue — Quarter Ended Jun 30, 2023
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The company's top line continued to show growth over the trailing twelve-month period.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue for the quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The company's top line continued to show growth over the trailing twelve-month period.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$943.6M
Revenue reported for this quarter.
Quarter-over-quarter
+4.8%
Change from the immediately preceding quarter.
Year-over-year
+9.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$3.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $841.7M | +3.9% |
| Dec 31, 2022 | $828.6M | +3.4% |
| Mar 31, 2023 | $900.2M | +7.6% |
| Jun 30, 2023 | $943.6M | +9.7% |
Revenue performance
Reported revenue rose from the prior quarter, reflecting a sequential increase. The pace of growth was also positive when measured against the same period one year ago.
Quarterly comparison
Compared with the immediately preceding quarter, revenue was higher. Compared with the same quarter one year earlier, revenue also showed an increase.
What to watch
Monitor trends in companion animal healthcare and distributor purchasing patterns as noted in the company's business overview.